Clinical Trial Update: The Role of Matrix Metalloproteinase 2 and 9 Enzymes in Developing Chronic Thromboembolic Pulmonary Hypertension

View source ↗

Summary

A completed clinical trial examining the role of matrix metalloproteinase 2 and 9 in chronic thromboembolic pulmonary hypertension, with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thromboembolic Pulmonary Hypertension

Snippet

Sponsor: AHMET ZENGIN | Conditions: Chronic Thromboembolic Pulmonary Hypertension | Status: COMPLETED | Results posted: 2021-08-10